BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 10600131)

  • 1. Anophelin: kinetics and mechanism of thrombin inhibition.
    Francischetti IM; Valenzuela JG; Ribeiro JM
    Biochemistry; 1999 Dec; 38(50):16678-85. PubMed ID: 10600131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unique thrombin inhibition mechanism by anophelin, an anticoagulant from the malaria vector.
    Figueiredo AC; de Sanctis D; Gutiérrez-Gallego R; Cereija TB; Macedo-Ribeiro S; Fuentes-Prior P; Pereira PJ
    Proc Natl Acad Sci U S A; 2012 Dec; 109(52):E3649-58. PubMed ID: 23223529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative analysis of the effectiveness of C-terminal cleavage intein-based constructs in producing a recombinant analog of anophelin, an anticoagulant from Anopheles albimanus.
    Esipov RS; Kostromina MA
    Appl Biochem Biotechnol; 2015 Mar; 175(5):2468-88. PubMed ID: 25503362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The isomorphous structures of prethrombin2, hirugen-, and PPACK-thrombin: changes accompanying activation and exosite binding to thrombin.
    Vijayalakshmi J; Padmanabhan KP; Mann KG; Tulinsky A
    Protein Sci; 1994 Dec; 3(12):2254-71. PubMed ID: 7756983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrostatic steering and ionic tethering in the formation of thrombin-hirudin complexes: the role of the thrombin anion-binding exosite-I.
    Myles T; Le Bonniec BF; Betz A; Stone SR
    Biochemistry; 2001 Apr; 40(16):4972-9. PubMed ID: 11305913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new class of potent thrombin inhibitors that incorporates a scissile pseudopeptide bond.
    DiMaio J; Ni F; Gibbs B; Konishi Y
    FEBS Lett; 1991 Apr; 282(1):47-52. PubMed ID: 2026264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional analyses yield detailed insight into the mechanism of thrombin inhibition by the antihemostatic salivary protein cE5 from
    Pirone L; Ripoll-Rozada J; Leone M; Ronca R; Lombardo F; Fiorentino G; Andersen JF; Pereira PJB; Arcà B; Pedone E
    J Biol Chem; 2017 Jul; 292(30):12632-12642. PubMed ID: 28592490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bothrojaracin: a potent two-site-directed thrombin inhibitor.
    Arocas V; Zingali RB; Guillin MC; Bon C; Jandrot-Perrus M
    Biochemistry; 1996 Jul; 35(28):9083-9. PubMed ID: 8703912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allosteric changes of thrombin catalytic site induced by interaction of bothrojaracin with anion-binding exosites I and II.
    Monteiro RQ; Rapôso JG; Wisner A; Guimarães JA; Bon C; Zingali RB
    Biochem Biophys Res Commun; 1999 Sep; 262(3):819-22. PubMed ID: 10471408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bifunctional peptide boronate inhibitors of thrombin: crystallographic analysis of inhibition enhanced by linkage to an exosite 1 binding peptide.
    Skordalakes E; Elgendy S; Goodwin CA; Green D; Scully MF; Kakkar VV; Freyssinet JM; Dodson G; Deadman JJ
    Biochemistry; 1998 Oct; 37(41):14420-7. PubMed ID: 9772168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification, cloning, and synthesis of a novel salivary anti-thrombin from the mosquito Anopheles albimanus.
    Valenzuela JG; Francischetti IM; Ribeiro JM
    Biochemistry; 1999 Aug; 38(34):11209-15. PubMed ID: 10460178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure of thrombin in complex with S-variegin: insights of a novel mechanism of inhibition and design of tunable thrombin inhibitors.
    Koh CY; Kumar S; Kazimirova M; Nuttall PA; Radhakrishnan UP; Kim S; Jagadeeswaran P; Imamura T; Mizuguchi J; Iwanaga S; Swaminathan K; Kini RM
    PLoS One; 2011; 6(10):e26367. PubMed ID: 22053189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet glycoprotein Ib alpha binds to thrombin anion-binding exosite II inducing allosteric changes in the activity of thrombin.
    Li CQ; Vindigni A; Sadler JE; Wardell MR
    J Biol Chem; 2001 Mar; 276(9):6161-8. PubMed ID: 11024046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in interactions in complexes of hirudin derivatives and human alpha-thrombin due to different crystal forms.
    Priestle JP; Rahuel J; Rink H; Tones M; Grütter MG
    Protein Sci; 1993 Oct; 2(10):1630-42. PubMed ID: 8251938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inactivation of thrombin by antithrombin is accompanied by inactivation of regulatory exosite I.
    Bock PE; Olson ST; Björk I
    J Biol Chem; 1997 Aug; 272(32):19837-45. PubMed ID: 9242645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetic mechanism for the interaction of Hirulog with thrombin.
    Parry MA; Maraganore JM; Stone SR
    Biochemistry; 1994 Dec; 33(49):14807-14. PubMed ID: 7993908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of fragments of hirudin to investigate thrombin-hirudin interaction.
    Dennis S; Wallace A; Hofsteenge J; Stone SR
    Eur J Biochem; 1990 Feb; 188(1):61-6. PubMed ID: 2180697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a substrate-like cleavage-resistant thrombin inhibitor from the saliva of the flea Xenopsylla cheopis.
    Lu S; Tirloni L; Oliveira MB; Bosio CF; Nardone GA; Zhang Y; Hinnebusch BJ; Ribeiro JM; Andersen JF
    J Biol Chem; 2021 Nov; 297(5):101322. PubMed ID: 34688666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of exosites 1 and 2 in thrombin reaction with plasminogen activator inhibitor-1 in the absence and presence of cofactors.
    Rezaie AR
    Biochemistry; 1999 Nov; 38(44):14592-9. PubMed ID: 10545182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The tick-derived anticoagulant madanin is processed by thrombin and factor Xa.
    Figueiredo AC; de Sanctis D; Pereira PJ
    PLoS One; 2013; 8(8):e71866. PubMed ID: 23951260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.